Literature DB >> 4521800

Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria.

C J Watson, I Bossenmaier, R Cardinal, Z J Petryka.   

Abstract

Hematin administered intravenously in a patient with congenital erythropoietic porphyria evidently entered erythrocyte precursors in the bone marrow, producing the well-known negative feedback repression of porphyrin biosynthesis with marked decline of porphyrin concentrations in urine, circulating plasma, and erythrocytes. A delay in the major segment of this effect corresponded roughly with the sum of the average transit times through the maturation compartments of the erythrocyte precursors. This delay was considerably longer than previously observed in the decline of porphyrin precursors after administration of hematin in patients with hepatic porphyria. The effect of hematin was compared with that of packed erythrocyte transfusions given at regular intervals in the same patient over a period of 2.5 years. In general, administration of hematin results in a reduction of porphyrin formation of the same order of magnitude, but of shorter duration, possibly in relation to the relatively small amounts of hematin infused.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4521800      PMCID: PMC387986          DOI: 10.1073/pnas.71.2.278

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A SUGGESTED CONTROL GENE MECHANISM FOR THE EXCESSIVE PRODUCTION OF TYPES I AND 3 PORPHYRINS IN CONGENITAL ERYTHROPOIETIC PORPHYRIA.

Authors:  C J WATSON; W RUNGE; L TADDEINI; I BOSSENMAIER; R CARDINAL
Journal:  Proc Natl Acad Sci U S A       Date:  1964-08       Impact factor: 11.205

2.  delta-aminolaevulate dehydratase from Rhodopseudomonas spheroides.

Authors:  B F BURNHAM; W S PIERCE; K R WILLIAMS; M H BOYER; C K KIRBY
Journal:  Biochem J       Date:  1963-06       Impact factor: 3.857

Review 3.  RECENT STUDIES IN ERYTHROID DIFFERENTIATION AND PROLIFERATION.

Authors:  L G LAJTHA
Journal:  Medicine (Baltimore)       Date:  1964-11       Impact factor: 1.889

Review 4.  BIOCHEMICAL LESIONS IN PORPHYRIA.

Authors:  D P TSCHUDY
Journal:  JAMA       Date:  1965-03-01       Impact factor: 56.272

5.  The synthesis of enzymes concerned in bacteriochlorophyll formation in growing cultures of Rhodopseudomonas spheroides.

Authors:  J LASCELLES
Journal:  J Gen Microbiol       Date:  1960-12

6.  Porphyrin content of bone marrow and liver in the various forms of porphyria.

Authors:  R SCHMID; S SCHWARTZ; C J WATSON
Journal:  AMA Arch Intern Med       Date:  1954-02

7.  Effect of hemin on the synthesis of hemoglobin and other proteins in mammalian cells.

Authors:  Y Beuzard; R Rodvien; I M London
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

8.  The use of exogenous -aminolaevulinic acid for the studies of the regulation of haem synthesis in rabbit reticulocytes.

Authors:  P Ponka; J Neuwirt; J Borová
Journal:  Biochim Biophys Acta       Date:  1973-03-30

9.  Family study in congenital erythropoietic porphyria.

Authors:  T Darocha; J Weremowicz; A Gregor
Journal:  S Afr Med J       Date:  1971-09-25

10.  Uroporphyrinogen 3 cosynthetase in bovine erythropoietic porphyria.

Authors:  E Y Levin
Journal:  Science       Date:  1968-08-30       Impact factor: 47.728

View more
  4 in total

1.  Congenital erythropoietic porphyria and congenital adrenal hyperplasia with evidence for hepatic delta-5 alpha-reductase deficiency.

Authors:  J A Miller; G M Levene
Journal:  J R Soc Med       Date:  1989-02       Impact factor: 5.344

2.  Heme status affects human hepatic messenger RNA and microRNA expression.

Authors:  Herbert L Bonkovsky; Weihong Hou; Nury Steuerwald; Qing Tian; Ting Li; Judy Parsons; Alicia Hamilton; Sunil Hwang; Laura Schrum
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

3.  Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.

Authors:  G S Drummond; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

4.  Postulated deficiency of hepatic heme and repair by hematin infusions in the "inducible" hepatic porphyrias.

Authors:  C J Watson; C A Pierach; I Bossenmaier; R Cardinal
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.